Pharmacosmos As patent expiration

1. Monoferric patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US10414831 PHARMACOSMOS AS Stable iron oligosaccharide compound
Mar, 2029

(4 years from now)

US8815301 PHARMACOSMOS AS Stable iron oligosaccharide compound
Aug, 2029

(5 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11633489 PHARMACOSMOS AS Iron carbohydrate complex for treatment of iron deficiency of a fetus or an infant
Jun, 2036

(11 years from now)




Drugs and Companies using FERRIC DERISOMALTOSE ingredient

Market Authorisation Date: 16 January, 2020

Treatment: Treatment of iron deficiency anemia (dia) in adults patients who have intolerance to oral iron or have had unsatisfactory response to oral iron, who have non-hemodialysis dependent chronic kidney dise...

Dosage: SOLUTION

More Information on Dosage

MONOFERRIC family patents

Family Patents